TKNO — Alpha Teknova Inc · rev $23.3M

Alpha Teknova Inc (TKNO) is a drug manufacturers - specialty & generic company listed on NASDAQ.

Latest reported TKNO revenue for 2026-06-30 was $23.3M. Net income was -$7.7M. TKNO currently screens at market cap $221.4M.

Use this TKNO page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the TKNO quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the TKNO SEC filings page. Lician reads the product cache first so this HTML stays unique to Alpha Teknova Inc even when a live quote feed is slow.

Alpha Teknova Inc latest statements (FY2025)

Latest cached year on this hub. Full TKNO income, balance, and cash tables.

  • Revenue$40.5M
  • Net Income-$17.3M
  • Total Assets$103.6M
  • Total Debt$0
  • Free Cash Flow-$9.8M